Form 4: Guardant Health Director Tariq Musa Reports Stock Transactions

Director Tariq Musa reports the acquisition and disposal of Guardant Health, Inc. common stock and restricted stock units.

Summary

• On April 15, 2025, Director Tariq Musa reported transactions involving Guardant Health, Inc. securities.
• These transactions included the acquisition of 250 shares of common stock at a price of $0.
• Musa also reported the disposal of 250 restricted stock units.
• Following these transactions, Musa beneficially owns 3,461 shares of common stock directly and 5,747 derivative securities.
• The restricted stock units vest over a four-year period, with 25% vesting on the one-year anniversary of March 15, 2023, and the remaining 75% vesting monthly over the subsequent three years.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting stock transactions by a company insider. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transactions.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for insiders of publicly traded companies, providing transparency into their trading activities. It doesn't necessarily reflect a broader industry trend but is specific to the individual's transactions and company's stock.

Stakeholder Impact

• The reported transactions may be of interest to shareholders as they provide insight into the trading activities of a company director.
• The transactions themselves are unlikely to have a significant impact on other stakeholders such as employees, customers, or suppliers.

Key Dates

Keywords

Form 4, Guardant Health, Tariq Musa, stock, restricted stock units, director, GH